CNBC's "American Greed" show features story about Phillips & Cohen's whistleblower case against Pfizer

CHICAGO, April 7, 2010 - The "qui tam" lawsuit brought against Pfizer by Phillips & Cohen LLP for the pharma company's off-label marketing of the prescription painkiller, Bextra, was the focus of a story broadcast tonight on CNBC's "American Greed."

Erika A. Kelton, a Phillips & Cohen partner who was the lead attorney on the whistleblower case, was interviewed for the story. The TV documentary also featured a New York Times reporter who covered the Pfizer case, Pfizer's chief compliance officer and a former sales representative for Pfizer whose identity was concealed.

Pfizer paid a record-breaking $1.8 billion in September 2009 to settle the qui tam case involving the off-label marketing of Bextra and a related criminal fine.

The show will air again on April 10 at 8 p.m. and 11 p.m. EST; April 11 at midnight; April 12 at 3 a.m. EST and April 14 at 8 p.m. EST. A preview of the show is posted on the "American Greed" website. The entire story will be available online in about two months.